Евразийская ассоциация снижения вреда (ЕАСВ) собрала информацию о возможностях получения бесплатной технической поддержки (ТП) в контексте ВИЧ и ТБ для НПО и организаций на базе сообществ в регионе ВЕЦА.
Пособие подготовлено в рамках проекта Региональной Платформы по коммуникации и координации в ВЕЦА, который реализуется при поддержке ...
On 26 September 2018, the United Nations (UN) will hold its first high-level meeting on tuberculosis (TB), at its headquarters in New York. The title of the meeting – United to End TB: An Urgent Global Response to a Global Epidemic – highlights the need for immediate action to accelerate ...
Major improvement in treatment outcomes and quality of life of patients with multidrug-resistant tuberculosis (MDR-TB) are expected, following key changes in MDR-TB treatment announced by WHO in the Rapid Communication.
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, ...
In 2015, governments across Europe and Central Asia committed themselves to achieve the Sustainable Development Goals (SDGs) and combatting hepatitis by 2030. The following year, at the World Health Assembly, they adopted the first WHO strategy on hepatitis, which calls for eliminating viral hepatitis as ...
This document provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Executive summary
Compared with the general public, people in ...
The importance of engaging all providers in tuberculosis (TB) care and prevention has been recognized for well over a decade. Over 4 million people with TB are missed each year by health systems and therefore do not get the care they need and deserve. A ...
The guide explains what global standards are for TB prevention, treatment, and care, so people with TB and their caregivers can know what services they have the right to receive.
About one third of the world’s population has latent tuberculosis (TB) infection and thus acts as a reservoir of Mycobacterium tuberculosis, the agent that causes active TB disease. More than 50 years after the first chemotherapeutic drugs for TB were introduced, the disease remains a ...
The World Health Organization (WHO) estimates that 10.4 million persons developed tuberculosis (TB) worldwide in 2016, corresponding to a global incidence of 140 TB cases per 100 000
population. Of those who developed TB, 1.0 million cases (10%) occurred among persons living with HIV. The worldwide ...
The purpose of WHO’s Global Tuberculosis Report is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in care and prevention at global, regional and country levels. This is done in the context of recommended global TB strategies and associated ...
People in prisons have a higher prevalence of several communicable diseases than the general population.
The objective of this report is to systematically review data on the diagnosis, treatment, care and prevention of tuberculosis in prison settings, with a focus on the countries of the European ...
Цель / постановка проблемы / вопрос исследования
Исследование было разработано главным образом для оценки статуса государственных противотуберкулезных программ в отношении последних рекомендаций ВОЗ в пяти областях: диагностика, модели лечения, лечение лекарственно-чувствительного и лекарственно-устойчивого туберкулеза, а также нормативная база для использования противотуберкулезных препаратов. Мы попытались, где это ...
Основною метою тисячоліття щодо протидії туберкульозу (ТБ) в усьому світі, включаючи Україну, є надання тенденції поширення ТБ зворотного руху. За підсумками 2015 року відмічається стабілізація та зменшення рівня захворюваності на ТБ майже в усіх регіонах України. Показник за- хворюваності зменшився на 0,8 у порівнянні з ...
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
